Skip to main content
OpenTrials

Clinical trial condition

Tenosynovial Giant Cell Tumor

Explore clinical trials studying Tenosynovial Giant Cell Tumor. Study availability and eligibility vary by location and protocol.

16 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Tenosynovial Giant Cell Tumor trial results

Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

NCT04192344

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +9 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
  • The Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 17 locations
View Trial Details
Recruiting

A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment

NCT04635111

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Hepatotoxicity, +10 more
Locations
  • Kamalesh K Sankhala MD INC Santa Monica, California, United States
  • Sarcoma Oncology Research Center LLC Santa Monica, California, United States
  • UCLA Hematology and Oncology Santa Monica, California, United States
  • The Oncology Institute of Hope and Innovation Whittier, California, United States
View Trial Details
Active, not recruiting

A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT

NCT04488822

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +9 more
Locations
  • Beijing Ji Shui Tan Hospital Beijing, China
  • Peking University Cancer Hospital Beijing, China
  • The First Affiliated Hospital, Sun Yat-sen University Guangzhou, China
  • The Second Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, China
View Trial Details
Active, not recruiting

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

NCT03069469

Conditions
Advanced Malignant Neoplasm, Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, +13 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Colorado - Denver Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
View all 24 locations
View Trial Details
Active, not recruiting

Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)

NCT05804045

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +11 more
Locations
  • Precision NextGen Oncology Beverly Hills, California, United States
  • Duke University Medical Center Durham, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View all 40 locations
View Trial Details
Active, not recruiting

Study of Vimseltinib for Tenosynovial Giant Cell Tumor

NCT05059262

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Colorado Aurora, Colorado, United States
  • University of Kansas Kansas City, Kansas, United States
View all 35 locations
View Trial Details
Completed

A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

NCT04703322

Conditions
Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +10 more
Locations
  • Nagoya University Hospital Aichi, Japan
  • Kyushu University Hospital Fukuoka, Japan
  • Kanazawa University Hospital Ishikawa, Japan
  • National Hospital Organization Osaka National Hospital Osaka, Japan
View Trial Details

Related conditions